CANAURAL
CANAURAL
Authorised
- Diethanolamine fusidate
- Prednisolone
- Nystatin
- Framycetin sulfate
Product identification
Medicine name:
CANAURAL
Active substance:
- Diethanolamine fusidate
- Prednisolone
- Nystatin
- Framycetin sulfate
Target species:
-
Dog
-
Cat
Route of administration:
-
Auricular use
-
Cutaneous use
Product details
Active substance and strength:
-
Diethanolamine fusidate4.99/milligram(s)1.00gram(s)
-
Prednisolone2.50/milligram(s)1.00gram(s)
-
Nystatin100000.00/international unit(s)1.00gram(s)
-
Framycetin sulfate6.05/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Ear drops, suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Dechra Veterinary Products A/S
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera d.d.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/2619460 0/1980
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 19/09/2025